Antiviral clinical trials taking place in Cleveland
By: Sylvia Rose
Posted: Mar 21, 2020 10:48 PM EDT
-
2:53
Local leaders call for transparency as Data Center conversations...
-
2:44
Pokagon Band, city of Dowagiac continue calls for data center...
-
3:32
South Bend Police Department share safety tips for short term...
-
1:11
Notre Dame professor Asher Kaufmann speaks on US blockades
-
0:25
Three rescued after Miner Street house fire; cat still missing
-
2:34
Hoosier state invests $200 million in affordable childcare, local...
-
1:58
Updated timings on storms, after midnight
-
1:50
St. Joseph County police urge caution on slick roads
-
1:32
Tracking storms after midnight
-
1:48
Severe weather is likely tonight for portions of Michiana
-
4:26
Phoenix Performing Arts debuts Tony-nominated show
-
3:55
New program supports kindergarten readiness
CLEVELAND, Ohio – University Hospitals in Cleveland are taking the next step in fighting COVID-19, securing two clinical trials that will provide an antiviral drug to adults who have been hospitalized with pneumonia due to the virus.
Leaders of the study are hoping to test around 1000 people nationwide.
"Because there's no other treatment now so it's really exciting to see a drug that could hit the virus itself, not just supportive care," said Dr. Grace McComsey, a doctor at University Hospitals.
The trial should provide information on whether the drug can help lower fevers and normalize oxygen saturation in patients.
The drug is federally regulated and was safely tested on more than 500 people during the Ebola outbreak.
Sign up for the ABC 57 Newsletter